Abstract:Background: Pseudo-ginsenoside-Rh2 (pseudo-G-Rh2), a novel derivative of ginseno-side Rh2, is reported to exert a pro-apoptotic effect on various malignancies. However, whether this anti-cancer action of pseudo-G-Rh2 involves autophagy remains to be determined and ex-plored. Objective: The objective of this study was to investigate the pseudo-G-Rh2-induced apoptosis and autophagy and the underlying mechanism. Methods: In the present study, the MTT assay was used for evaluating cell viability, and the lactate dehydrogenase (LDH) assay was performed to assess cell toxicity. Autophagy evaluation was per -formed using monodansylcadaverine (MDC) staining and transmission electron microscopy (TEM). The levels of autophagy-associated and apoptosis-associated proteins were determined us -ing Western blotting. The Annexin V-FITC/propidium iodide (PI) assay was used to assess apopto-sis. Results: The Annexin V-FITC/PI assay revealed that the percentage of apoptotic cells in HepG2 cells at concentrations 0, 20, 40, and 60 mu M was 3.75%+/- 1.37%, 5.70%+/- 1.04%, 12.30%+/- 2.10%, and 34.26%+/- 4.73%, respectively. Pseudo-G-Rh2 was observed to significantly increase the expres-sions of BAX, cleaved-caspase-3, and cleaved-caspase-9, while it decreased the Bcl-2 expression. MDC and TEM analysis revealed that pseudo-G-Rh2 at concentrations 20, 40, and 60 mu M signifi-cantly facilitated the accumulation of autophagosomes and autolysosomes within the HepG2 cells. Moreover, pseudo-G-Rh2 significantly increased the expressions of LC3 II/LC3 I and Beclin-1 and decreased the expression of p62. The Annexin V-FITC/PI assay also revealed that in comparison to the pseudo-G-Rh2 group, the concurrent treatment with pseudo-G-Rh2 and an autophagy inhibitor (CQ or 3-MA) significantly induced distinct apoptosis. In addition, pseudo-G-Rh2 activated AMPK and inhibited the PI3K/Akt/mTOR pathway in a concentration-dependent manner. Pseu-do-G-Rh2 is similar to the current patents, which enhanced its anti-cancer activity by combining with autophagy inhibitors. Conclusion: Pseudo-G-Rh2 could induce protective autophagy in HepG2 cells, at least in part, via AMPK and the PI3K/Akt/mTOR pathway.

Ginsenoside Rk1 induces autophagy-dependent apoptosis in hepatocellular carcinoma by AMPK/mTOR signaling pathway

Ginsenoside Rk3 is a Novel PI3K/AKT-targeting Therapeutics Agent That Regulates Autophagy and Apoptosis in Hepatocellular Carcinoma

Ginsenoside Rk1 Regulates Glutamine Metabolism in Hepatocellular Carcinoma Through Inhibition of the ERK/c-Myc Pathway

Ginsenoside Rk1 Induces Apoptosis and Downregulates the Expression of PD-L1 by Targeting the NF-κB Pathway in Lung Adenocarcinoma

Ginsenoside Rk3 Suppresses Hepatocellular Carcinoma Development Through Targeting the Gut-Liver Axis.

Ginsenoside Rg3 Inhibit Hepatocellular Carcinoma Growth Via Intrinsic Apoptotic Pathway.

Ginsenoside metabolite compound K induces apoptosis and autophagy in non-small cell lung cancer cells via AMPK/mTOR and JNK pathways.

Ginsenoside Rg5 Induces Apoptosis and Autophagy Via the Inhibition of the PI3K/Akt Pathway Against Breast Cancer in a Mouse Model

Ginsenoside Rk1 inhibits cell proliferation and promotes apoptosis in lung squamous cell carcinoma by calcium signaling pathway

Ginsenoside compound K induces mitochondrial apoptosis in human hepatoma cells through Bclaf1-mediated modulation of ERK signaling

The Ginsenoside Rk3 Exerts Anti-Esophageal Cancer Activity in Vitro and in Vivo by Mediating Apoptosis and Autophagy Through Regulation of the PI3K/Akt/mTOR Pathway.

Ginsenoside Rk1 Induces Cell Cycle Arrest and Apoptosis in MDA-MB-231 Triple Negative Breast Cancer Cells.

Pseudo-ginsenoside Rh2 Induces Protective Autophagy in Hepatocellular Carcinoma HepG2 Cells

Ginsenoside Rh2 Inhibits Hepatocellular Carcinoma Through Β-Catenin and Autophagy

Hepatoprotective Effects of Ginsenoside Rk3 in Acetaminophen-Induced Liver Injury in Mice by Activation of Autophagy.

Ginsenoside CK, rather than Rb1, possesses potential chemopreventive activities in human gastric cancer via regulating PI3K/AKT/NF-κB signal pathway

Ginsenoside Rg1 alleviates acute liver injury through the induction of autophagy and suppressing NF-κB/NLRP3 inflammasome signaling pathway

Compound K Induces Endoplasmic Reticulum Stress and Apoptosis in Human Liver Cancer Cells by Regulating STAT3.

Ginsenoside Rb1 Inhibits the Proliferation of Lung Cancer Cells by Inducing the Mitochondrial-mediated Apoptosis Pathway

Ginsenoside Rg1 Inhibits Apoptosis by Increasing Autophagy Via the AMPK/mTOR Signaling in Serum Deprivation Macrophages.

Ginsenoside Rk1 Ameliorates ER Stress-Induced Apoptosis through Directly Activating IGF-1R in Mouse Pancreatic [math]-Cells and Diabetic Pancreas